Results 31 to 40 of about 1,439 (152)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization

open access: yesTherapeutics and Clinical Risk Management, 2021
Oriana Simonetti,1,* Giulio Rizzetto,1,* Elisa Molinelli,1 Oscar Cirioni,2 Annamaria Offidani1 1Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 2Clinic of Infectious Diseases ...
Simonetti O   +4 more
doaj  

Cancer is chronic but antimicrobial stewardship is iconic: A retrospective cohort of optimal antibiotic use in ambulatory oncology clinics

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2023
Objective: To evaluate antibiotic prescribing in ambulatory oncology clinics and to identify opportunities to improve antibiotic use. Methods: Retrospective cohort of adult patients who received care at 4 ambulatory oncology clinics from May 2021 to ...
Tiffany A. Ho   +4 more
doaj   +1 more source

Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence

open access: yesInfection and Drug Resistance, 2022
Daniele Roberto Giacobbe,1,2 Silvia Dettori,1,2 Silvia Corcione,3 Antonio Vena,1,2 Chiara Sepulcri,1,2 Alberto Enrico Maraolo,4 Francesco Giuseppe De Rosa,3 Matteo Bassetti1,2 1Clinica Malattie Infettive, Ospedale Policlinico San Martino – IRCCS, Genoa ...
Giacobbe DR   +7 more
doaj  

Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial

open access: yesInfectious Diseases and Therapy, 2019
Introduction Admissions for acute bacterial skin and skin structure infections (ABSSSI) are often prolonged because of intravenous (IV) antibiotics. Use of a long-acting IV antibiotic may reduce length of stay (LOS) on a hospitalist service.
Matthew W. McCarthy   +6 more
doaj   +1 more source

Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis

open access: yesBMC Infectious Diseases, 2021
Background Delafloxacin is a novel fluoroquinolone with broad antibacterial activity against pathogens causing acute bacterial skin and skin structure infections (ABSSSI).
Ioanna Vlachaki   +6 more
doaj   +1 more source

Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 18, Issue 12, Page 1417-1424, December 2020., 2020
Summary Background and objectives Erysipelas, caused by beta‐hemolytic streptococci, and limited cellulitis, frequently caused by Staphylococcus aureus or other bacteria, are skin and soft tissue infections characterized by typical clinical signs. However, despite the therapeutical relevance they are often not differentiated (e.g in clinical trials ...
Christian Drerup   +3 more
wiley   +1 more source

Diagnostischer Wert von Laborparametern zur Unterscheidung zwischen Erysipel und begrenzter Phlegmone

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 18, Issue 12, Page 1417-1425, December 2020., 2020
Zusammenfassung Hintergrund und Ziele Das Erysipel, hervorgerufen durch beta‐hämolysierende Streptokokken, und die begrenzte Phlegmone, häufig ausgelöst durch Staphylococcus aureus oder andere Bakterien, sind Infektionen der Haut und des Weichteilgewebes mit typischen klinischen Symptomen. Allerdings wird oft (etwa in klinischen Studien) nicht zwischen
Christian Drerup   +3 more
wiley   +1 more source

Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments [PDF]

open access: yes, 2018
Background The objective of this study was to characterize treatment of patients with acute bacterial skin and skin structure infections (ABSSSIs) and describe the association between hospital admission and emergency department (ED ...
Gllard, Patrick   +29 more
core   +1 more source

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

open access: yesGMS Infectious Diseases, 2019
Complicated infections such as osteomyelitis, skin and soft tissue infections or endocarditis often require antibiotic therapies that can last up to several weeks. The prolonged hospital length of stay (LOS) leads to a dramatic increase in costs.
Wilke, Michael   +5 more
doaj   +1 more source

Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.

open access: yesPLoS ONE, 2021
BackgroundOritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults with acute bacterial skin and skin structure infections (ABSSSI).
Kimberly Saddler   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy